Should Ozempic be part of your lupus or RA treatment strategy Learn what we know so far [MlfbLZkNZWbI]
| 1h 28m 28s | Video has closed captioning.
Can Ozempic (or similar drugs) hold the key to managing both metabolic syndrome and autoimmune diseases like lupus and rheumatoid arthritis? Learn how addressing metabolic health could impact inflammation, and discover if drugs like Ozempic might be a game-changer for your treatment strategy!
🔗 Links:
Your Appointment Home Run Handbook - https://bit.ly/4heAouK
The guide you need to tell your doc your story -and get answers once and for all!
🎥 watch more:
Top 10 Things to know about lupus - part 1: https://youtu.be/EYdwBolnIY0
Top 10 Things to know about lupus - part 2: https://youtu.be/E8apzzRaRhY
How to treat Rheumatoid Arthritis pt 1: https://youtu.be/nfEgg4UY1nE
How to treat Rheumatoid Arthritis pt 2: https://youtu.be/padypfbiqb0
💡Video Key Takeaways
✅ Autoimmune conditions like lupus and RA are often associated with metabolic syndrome, which contributes to inflammation and worsens disease outcomes.
✅ GLP-1 agonists like Ozempic, primarily used for diabetes, exhibit potential anti-inflammatory effects and are being explored for their role in managing inflammation alongside metabolic health.
✅ While there is no current evidence that medications like Ozempic can have a substantial impact on autoimmune disease activity there may be a role in addressing concurrent metabolic syndrome in those with autoimmune disease.
✅ Patients are encouraged to discuss symptoms of insulin resistance and potential treatment options, including medications like Ozempic, with their healthcare providers.
⏱️Time Stamps:
00:00 Intro
0:55 It’s about Metabolic Syndrome
3:05 Metabolic Syndrome & Autoimmunity
4:37 Ozempic & GLP-1 Agonists
6:45 Convo Starters (Qs for you and you doctor)
📖 References:
1. Malavazos AE, et al. Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes. Endocrinol Diabetes Metab Case Rep. 2023 Aug 8;2023(3):23-0017.
2. Dubovyk V, et al. Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study. RMD Open. 2024 Apr 4;10(2):e004227.
3. Medina G, et al. Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res. 2018 Jul;133:277-288.
4. Gomez A, et al. Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study. Rheumatol Int. 2024 May;44(5):851-861.
5. Yaribeygi H, et al. Anti-inflammatory benefits of semaglutide: State of the art. J Clin Transl Endocrinol. 2024 Mar 28;36:100340.
⌨️ Contact us for business inquiries: [email protected]
**Please note - we do not provide medical advice, opinions or diagnosis via email, phone or social media messaging.
👩🏻⚕️ About me:
Hello! I am Dr. Elizabeth Ortiz and I’m so happy you are here. I am a double board certified Rheumatologist with over 15 years experience practicing Rheumatology and am passionate about teaching & empowering patients to partner with their doctor.
** The information in this video is not intended nor implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained in this video is for general information purposes only and does not replace a consultation with your own doctor/health professional. Any comments and/or recommendations made in the comment section by anyone other than Connected Rheumatology does not reflect the opinion or recommendation of Connected Rheumatology.** #How SUGAR Addiction is Slowly Killing Your Weight Loss Efforts - and How to STOP It # 20 minute Walking Workout for Weight Loss Walk at Home Full Body # The American Revolution - OverSimplified Part 1
Aired: November 26, 2024
Buy Now:
Problems Playing Video? | Closed Captioning





